Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marko Babjuk
Observed names:
M Babjuk,
M. Babjuk,
M.B. Babjuk
Institution:
Fakultní nemocnice Motol a Homolka
Observed institutions:
Charles University,
University Hospital in Motol,
General University Hospital in Prague,
Fakultní nemocnice Motol a Homolka
OpenAlex ID:
A5040161008
Importance of miR-20a expression in prostate cancer tissue.
2010
·
M Pesta
, J Klecka
, et al.
·
PubMed
·
49
Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: An European Association of Urology Guidelines systematic review
2018
·
B. Peyronnet
, T. Seisen
, et al.
·
European Urology Supplements
·
18
PDF
Molecular cytogenetic characterization and diagnostics of bladder cancer.
2007
·
L Houskova
, Z Zemanova
, et al.
·
PubMed
·
18
Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: A systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer
2018
·
J.L. Dominguez Escrig
, B. Peyronnet
, et al.
·
European Urology Supplements
·
8
Prognostic value of the 1973 and 2004/2016 WHO grading systems in primary Ta/T1 non-muscle invasive urothelial carcinoma of the bladder: A multicenter EAU NMIBC guidelines panel study
2019
·
B.W.G. Van Rhijn
, M. Burger
, et al.
·
European Urology Supplements
·
3
1001 The impact of re-TUR on clinical outcomes in a large cohort of t1g3 patients treated with BCG
2014
·
P. Gontero
, R. Sylvester
, et al.
·
European Urology Supplements
·
3
Mp13-03 Impact of Synchronous Bladder Cancer on Recurrence-free Survival After Surgical Treatment for Primary Urethral Cancer: Results From the International Collaboration on Primary Urethral Carcinoma (icpuc)
2014
·
Georgios Gakis
, Jason A. Efstathiou
, et al.
·
The Journal of Urology
·
3
Integration of surgery and molecular targeted therapy in advanced renal cell carcinoma
2011
·
Milan Hora
, Petr Stránský
, et al.
·
Česká urologie
·
3
PDF
Risk tables for predicting progression using the 1973 and 2004/2016 WHO grading classification systems in primary Ta/T1 non-muscle invasive urothelial carcinoma of the bladder: A multicenter EAU NMIBC guidelines panel study
2020
·
R.J. Sylvester
, M. Burger
, et al.
·
European Urology Open Science
·
2
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
2019
·
A.E. Hentschel
, B.W.G. Van Rhijn
, et al.
·
European Urology Supplements
·
2
601 Role of conventional cytology in the treatment of upper tract urothelial carcinoma (OSS-UTUC): Results from the multi-institutional organ-sparing-UTUC collaboration
2013
·
E. Comploj
, M. Babjuk
, et al.
·
European Urology Supplements
·
2
C87 Erectile Dysfunction in Patients After Radical Prostatectomy
2010
·
O. Capoun
, T. Hanus
, et al.
·
European Urology Supplements
·
2
New trends in prostate cancer diagnostics
2022
·
O Příman
, Š Veselý
, et al.
·
Perspectives in Surgery
·
1
Management of BCG failure in non-muscle-invasive bladder cancer − the present and the future
2022
·
J Horňák
, A Brisuda
, et al.
·
Perspectives in Surgery
·
1
872 Long-term immunotherapy by dendritic-cells based vaccine in patients with PSA-recurrent prostate cancer
2014
·
L.J. Jarolim
, R. Spisek
, et al.
·
European Urology Supplements
·
1
Expression of BCL-2 and BAX-1 genes in the tissue of Ta, T1 urothelial carcinoma and their prognostic value
2013
·
Monika Szakácsová
, Viktor Soukup
, et al.
·
Česká urologie
·
1
PDF
943 Prognostic Factors and Outcomes After Definitive Treatment for Primary Urethral Cancer: Results From the International Collaboration on Primary Urethral Carcinoma
2013
·
Georgios Gakis
, Sia Daneshmand
, et al.
·
The Journal of Urology
·
1
C40 Phase I/ii of Clinical Study of Prostate Cancer Immunotherapy Using Dendritic Cell Vaccination Strategy – First Results
2010
·
I. Minárik
, R. Horváth
, et al.
·
European Urology Supplements
·
1
[Cystectomy in the treatment of bladder cancer].
2007
·
M Babjuk
, T Hanus
, et al.
·
PubMed
·
1
[Expression of PAX2 and PAX8 genes in conventional type of renal carcinoma and their role in the tumor prognosis].
2005
·
T Viktorová
, M Babjuk
, et al.
·
PubMed
·
1
[Fluorescence cystoscopy using 5-aminolevulinic acid].
2003
·
M Jirsa
, M Babjuk
, et al.
·
PubMed
·
1
Accuracy of novel urinary biomarker tests for diagnosis and surveillance of NMIBC: A systematic review, diagnostic test accuracy and network meta-analyses
2021
·
E. Laukhtina
, S.R. Shim
, et al.
·
European Urology Open Science
Safety and efficacy of A1H in patients with non-muscle invasive bladder cancer awaiting transurethral surgery: A randomized placebo controlled phase I/II study
2020
·
A. Brisuda
, J. Háček
, et al.
·
European Urology Open Science
Serum thymidine kinase 1 level correlates with the presence of prostate cancer
2018
·
J. Řezáč
, S. Veselý
, et al.
·
European Urology Supplements
Determination of serum level of PAPP-A in patients with clear cell renal cell carcinoma
2017
·
M. Čechová
, M. Koldová
, et al.
·
European Urology Supplements
Show more works
View as search
Works count:
48
Citation count:
122
H-index:
4
I10-index:
3
Year
Topic
Type